ADAMTS‐13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences
- 6 April 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (5), 955-962
- https://doi.org/10.1111/j.1538-7836.2006.01833.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Binding of ADAMTS13 to von Willebrand FactorPublished by Elsevier BV ,2005
- Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasJournal of Thrombosis and Haemostasis, 2004
- Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpuraBlood, 2004
- Assays of ADAMTS-13 activitySeminars in Hematology, 2004
- Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to EuropeansBlood Coagulation & Fibrinolysis, 2003
- An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpuraCurrent Opinion in Neurology, 2003
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002
- Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein IbαBlood, 2001
- Antithrombotic Effect of Platelet Glycoprotein Ib–Blocking Monoclonal Antibody Fab Fragments in Nonhuman PrimatesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975